Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Wilkinson, Tom M, Li, Chris K F, Chui, Cecilia S C, Huang, Arthur K Y, Perkins, Molly, Liebner, Julia C, Lambkin-Williams, Rob, Gilbert, Anthony +7 more·2012·Nature Medicine
DOI 10.1038/nm.2612

Cited by (982)

Items 201–300 of 982

  1. Influenza A Virus Infection in Pigs Attracts Multifunctional and Cross-Reactive T Cells to the Lung
    Stephanie C. Talker, Maria Stadler, Hanna C. Koinig, Kerstin H. Mair, Irene Magdalena Rodríguez-Gómez, Robert Graage, Roland Zell, Ralf Dürrwald, Elke Starick, Timm Harder et al. · 2016 · Journal of Virology
  2. Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine
    Daniil A. Korenkov, Исакова-Сивак Ирина Николаевна, Руденко Лариса Георгиевна · 2018 · Expert Review of Vaccines
  3. Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
    Matthew K. Siggins, Ryan S. Thwaites, Peter Openshaw · 2021 · Trends in Microbiology
  4. A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans
    Olga Pleguezuelos, Stuart Robinson, Ana Fernández, Gregory A. Stoloff, Alex Mann, Anthony Gilbert, Ganesh Balaratnam, Tom M. A. Wilkinson, Rob Lambkin‐Williams, JOHN S. OXFORD et al. · 2015 · Clinical and Vaccine Immunology
  5. A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety
    James N. Francis, Campbell Bunce, Claire Horlock, Jeannette M. Watson, Steve Warrington, Bertrand Georges, Carlton B. Brown · 2014 · Vaccine
  6. IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4 + T cells for heterosubtypic protection
    Sophie A. Valkenburg, Olive T. W. Li, Polly W. Y. Mak, Chris Ka Pun Mok, John Malcolm Nicholls, Yi Guan, Thomas A. Waldmann, Malik J. S. Peiris, Liyanage P. Perera, Leo L. M. Poon · 2014 · Proceedings of the National Academy of Sciences
  7. Progress in developing virus-like particle influenza vaccines
    Fu‐Shi Quan, Young‐Tae Lee, Ki‐Hye Kim, Min Chul Kim, Sang‐Moo Kang · 2016 · Expert Review of Vaccines
  8. Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
    David Gordon, Dimitar Sajkov, Yoshikazu Honda‐Okubo, Samuel Wilks, Malet Aban, Ian Barr, Nikolai Petrovsky · 2016 · Vaccine
  9. Pulmonary immunity to viruses
    S. Rameeza Allie, Troy D. Randall · 2017 · Clinical Science
  10. IL-12 and IL-7 synergize to control mucosal-associated invariant T-cell cytotoxic responses to bacterial infection
    Joshua C. Wallington, Anthony Peter Williams, Karl J. Staples, Tom M. A. Wilkinson · 2017 · Journal of Allergy and Clinical Immunology
  11. SIMON, an Automated Machine Learning System, Reveals Immune Signatures of Influenza Vaccine Responses
    Adriana Tomić, Ivan Tomic, Yael Rosenberg‐Hasson, Cornelia L. Dekker, Holden Terry Maecker, Mark M. Davis · 2019 · The Journal of Immunology
  12. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells
    Benjamin J. Meckiff, Kristin Ladell, James E. McLaren, Gordon B. Ryan, Alison M. Leese, Eddie A. James, David A. Price, Heather M. Long · 2019 · The Journal of Immunology
  13. Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
    Aleks Guvenel, Agnieszka Jóźwik, Stephanie Ascough, Seng Kuong Anakin Ung, Suzanna Paterson, Mohini Kalyan, Zoe Gardener, Emma Bergstrom, Satwik Kar, Maximillian S. Habibi et al. · 2019 · Journal of Clinical Investigation
  14. Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation
    Sushila A. Toulmin, Chaitali Bhadiadra, Andrew J. Paris, Jeffrey H. Lin, Jeremy B. Katzen, Maria Ciocca Basil, Edward E. Morrisey, George Scott Worthen, Laurence Crane Eisenlohr · 2021 · Nature Communications
  15. The Application of Single‐Cell RNA Sequencing in Vaccinology
    Andrés Noé, Tamsin N. Cargill, Carolyn M. Nielsen, Andrew J. C. Russell, Eleanor J. Barnes · 2020 · Journal of Immunology Research
  16. Immune Control of Avian Influenza Virus Infection and Its Vaccine Development
    Piyush Dey, Akanksha Ahuja, Jaishal Panwar, Poonam Choudhary, Shital Rani, Mandeep Kaur, Akanksha Sharma, Jatinder K. Kaur, Ashok Kumar Yadav, Vikas Sood et al. · 2023 · Vaccines
  17. Defining the balance between optimal immunity and immunopathology in influenza virus infection
    Thi H. O. Nguyen, Louise C. Rowntree, Brendon Yew Loong Chua, Ryan S. Thwaites, Katherine Kedzierska · 2024 · Nature reviews. Immunology
  18. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection
    Julie M. Fox, Leo K. Sage, Lei Huang, James P. Barber, Kimberly D. Klonowski, Andrew L. Mellor, Stephen Mark Tompkins, Ralph A. Tripp · 2013 · Journal of General Virology
  19. The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
    Brian J. Ward, Stéphane Pillet, Nathalie Charland, Sonia Trépanier, Julie Couillard, Nathalie Landry · 2017 · Human Vaccines & Immunotherapeutics
  20. Universal immunity to influenza must outwit immune evasion
    Sergio M. Quiñones‐Parra, Liyen Loh, Lorena E. Brown, Katherine Kedzierska, Sophie A. Valkenburg · 2014 · Frontiers in Microbiology
  21. Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
    Martin J. Scurr, George Lippiatt, Lorenzo Capitani, Kirsten Bentley, Sarah N. Lauder, Kathryn Smart, Michelle S. Somerville, Tara Rees, Richard James Stanton, Awen Gallimore et al. · 2022 · Nature Communications
  22. Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines
    Gunnveig Grødeland, Even Fossum, Bjarne Bogen · 2015 · Frontiers in Immunology
  23. Cross-reactive human B cell and T cell epitopes between influenza A and B viruses
    Masanori Terajima, Jenny Aurielle B. Babon, Mary Dawn T. Co, Francis A. Ennis · 2013 · Virology Journal
  24. Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses
    Marine L. B. Hillaire, Stella E. Vogelzang-van Trierum, Joost H. C. M. Kreijtz, Gerrie de Mutsert, Ron A. M. Fouchier, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan · 2012 · Journal of General Virology
  25. The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics
    Rob Lambkin‐Williams, Nicolas Noulin, Alex Mann, Andrew P. Catchpole, Anthony S. Gilbert · 2018 · Respiratory Research
  26. Opportunities and challenges for T cell-based influenza vaccines
    Tim R. Mosmann, Andrew James McMichael, Alexandre LeVert, John W. McCauley, Jeffrey W. Almond · 2024 · Nature reviews. Immunology
  27. Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model
    Graeme E. Price, Chia-Yun Lo, Julia A. Misplon, Suzanne L. Epstein · 2014 · Journal of Virology
  28. Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study
    Sook‐San Wong, Christine M. Oshansky, Xi-zhi J. Guo, Jacqui Ralston, Timothy Wood, Ruth Seeds, E. Claire Newbern, Ben Waite, Gary Reynolds, Marc‐Alain Widdowson et al. · 2017 · The Journal of Infectious Diseases
  29. Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice
    Shannon M. Miller, Van Cybulski, Margaret Whitacre, Laura S. Bess, Mark T. Livesay, Lois M. Walsh, David J. Burkhart, Hélène G. Bazin, Jay T. Evans · 2020 · Frontiers in Immunology
  30. Extracellular traps released by antimicrobial TH17 cells contribute to host defense
    George W. Agak, Alice Mouton, Rosane M. B. Teles, Thomas A. Weston, Marco Morselli, Priscila Ribeiro Andrade, Matteo A. Pellegrini, Robert L. Modlin · 2020 · Journal of Clinical Investigation
  31. Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection
    Masaaki Miyazawa · 2020 · Inflammation and Regeneration
  32. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
    I. Cassaniti, E. Percivalle, F. Bergami, A. Piralla, G. Comolli, R. Bruno, M. Vecchia, M. Sambo, M. Colaneri, V. Zuccaro et al. · 2021 · Clinical Microbiology and Infection
  33. Immunodominant CD4+T-Cell Responses to Influenza A Virus in Healthy Individuals Focus on Matrix 1 and Nucleoprotein
    Li Chen, Damien J. Zanker, Kun Xiao, Chao Wu, Quanming Zou, Weisan Chen · 2014 · Journal of Virology
  34. Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
    Timothy J. Powell, Yanchun Peng, Tamara Katherine Berthoud, Marie‐Ève Blais, Patrick J. Lillie, Adrian V. S. Hill, Sarah Rowland‐Jones, Andrew James McMichael, Sarah C. Gilbert, Tao Dong · 2013 · PLoS ONE
  35. Effect of Influenza A(H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses
    Jennifer Lynn Nayak, Katherine A. Richards, Hongmei Yang, John Jay Treanor, Andrea J. Sant · 2014 · The Journal of Infectious Diseases
  36. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges
    Manish M. Patel, Ian A. York, Arnold S. Monto, Mark G. Thompson, Alicia M. Fry · 2021 · The Lancet Microbe
  37. Aging and Options to Halt Declining Immunity to Virus Infections
    Miguel Ángel Palacios-Pedrero, Albert D. M. E. Osterhaus, Tanja Becker, Husni Elbahesh, Guus F. Rimmelzwaan, Giulietta Saletti · 2021 · Frontiers in Immunology
  38. A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting
    Jeffrey J. VanWormer, Maria E. Sundaram, Jennifer K. Meece, Edward A. Belongia · 2014 · BMC Infectious Diseases
  39. Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection
    Pin‐Hung Lin, Weng-In Wong, Yilan Wang, Meng-Ping Hsieh, Chia‐Wen Lu, Chieh-Yu Liang, Sung-Hsiang Jui, Fangyi Wu, Pei‐Jer Chen, Hung‐Chih Yang · 2018 · Mucosal Immunology
  40. Rational development of a combined mRNA vaccine against COVID-19 and influenza
    Qing Ye, Mei Wu, Chao Hui ZHOU, Xishan Lu, Baoying Huang, Ning Zhang, Hui John Zhao, Hang Chi, Xiao‐Jing Zhang, Dandan Ling et al. · 2022 · npj Vaccines
  41. Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level
    Maria Carollo, Raffaella Palazzo, Manuela Bianco, Elisabetta Pandolfi, Paola Chionne, Giorgio Fedele, Alberto Eugenio Tozzi, Rita Carsetti, Luisa Romanò, Clara Maria Ausiello · 2012 · Vaccine
  42. Ageing and respiratory infections: The airway of ageing
    Kamran Haq, Janet E. McElhaney · 2014 · Immunology Letters
  43. Memory T Cell Dynamics in the Lung during Influenza Virus Infection
    Angela Pizzolla, Linda M. Wakim · 2019 · The Journal of Immunology
  44. Intranasal Delivery of Influenza rNP Adjuvanted with c-di-AMP Induces Strong Humoral and Cellular Immune Responses and Provides Protection against Virus Challenge
    María Victoria Sánchez, Thomas Ebensen, Kai Schulze, Diego Esteban Cargnelutti, Paulina Błażejewska, Eduardo Alberto Scodeller, Carlos A. Guzmán · 2014 · PLoS ONE
  45. Induction of Gag-Specific CD4 T Cell Responses during Acute HIV Infection Is Associated with Improved Viral Control
    Miriam Schieffer, Heiko K. Jessen, Alexander F. Oster, Franco Pissani, Damien Z. Soghoian, Richard Lu, Arne B. Jessen, Carmen Zedlack, Bruce T. Schultz, Isaiah Davis et al. · 2014 · Journal of Virology
  46. Virus-Specific Antibody Secreting Cell, Memory B-cell, and Sero-Antibody Responses in the Human Influenza Challenge Model
    Kuan-Ying Arthur Huang, Chris Ka‐fai Li, Elizabeth Clutterbuck, Cecilia Chui, Tom M. A. Wilkinson, Anthony Gilbert, JOHN S. OXFORD, Rob Lambkin‐Williams, Tzou‐Yien Lin, Andrew James McMichael et al. · 2014 · The Journal of Infectious Diseases
  47. Development of Cross-Protective Influenza A Vaccines Based on Cellular Responses
    Peter Christiaan Soema, Elly van Riet, Gideon F. A. Kersten, Jean‐Pierre Amorij · 2015 · Frontiers in Immunology
  48. Cross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive Individuals
    Jun Liu, Shihong Zhang, Shuguang Tan, Yong Sub Yi, Bin Wu, Bin Cao, Fengcai Zhu, Chen Wang, Hua Wang, Jianxun Qi et al. · 2012 · Journal of Virology
  49. Fc functional antibodies in humans with severe H7N9 and seasonal influenza
    Hillary A. Vanderven, Lu Liu, Fernanda Ana‐Sosa‐Batiz, Thi H. O. Nguyen, Yanmin Wan, Bruce D. Wines, Philip Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew Sidney Parsons et al. · 2017 · JCI Insight
  50. In Silico Vaccine Strain Prediction for Human Influenza Viruses
    Thorsten R. Klingen, Susanne Reimering, Carlos A. Guzmán, Alice Carolyn McHardy · 2017 · Trends in Microbiology
  51. Engineering a Model to Study Viral Infections: Bioprinting, Microfluidics, and Organoids to Defeat Coronavirus Disease 2019 (COVID-19)
    Anastasia I. Shpichka, Polina Bikmulina, Maria Peshkova, Nastasia V. Kosheleva, Зурина Ирина Михайловна, Ensieh Zahmatkesh, Niloofar Khoshdel Rad, Marina Lipina, Е. Н. Голубева, Denis V. Butnaru et al. · 2020 · International Journal of Bioprinting
  52. Current Vaccine Platforms in Enhancing T-Cell Response
    Takehiro Ura, Masaki Takeuchi, Tatsukata Kawagoe, Nobuhisa Mizuki, Kenji Okuda, Masaru Shimada · 2022 · Vaccines
  53. Bidirectional Communication Between the Innate and Adaptive Immune Systems
    Kathrynne A. Warrick, Charles N. Vallez, Hannah E. Meibers, Chandrashekhar Pasare · 2025 · Annual Review of Immunology
  54. Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFNβ
    Karl J. Staples, Ben Nicholas, Richard McKendry, Cosma Mirella Spalluto, Joshua C. Wallington, Craig W. Bragg, Emily C. Robinson, Kirstin Martin, Ratko Djukanović, Tom M. A. Wilkinson · 2015 · PLoS ONE
  55. Magnitude and kinetics of multifunctional CD4+ and CD8β+ T cells in pigs infected with swine influenza A virus
    Stephanie C. Talker, Hanna C. Koinig, Maria Stadler, Robert Graage, Eva Klingler, Andrea Ladinig, Kerstin H. Mair, Sabine Elisabeth Hammer, Herbert Weißenböck, Ralf Dürrwald et al. · 2015 · Veterinary Research
  56. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines
    Aitor Nogales, Marta L. DeDiego, David J. Topham, Luis Martínez‐Sobrido · 2016 · Journal of Virology
  57. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
  58. Reactive oxygen species associated immunoregulation post influenza virus infection
    Lan Wang, Zheng Cao, Zi Wang, Jimin Guo, Jing Wen · 2022 · Frontiers in Immunology
  59. Correlates of protection against influenza infection in humans — on the path to a universal vaccine?
    Chris Ka-fai Li, Rino Rappuoli, Xiao‐Ning Xu · 2013 · Current Opinion in Immunology
  60. Inflammation Enhances IL-2 Driven Differentiation of Cytolytic CD4 T Cells
    Aspen M. Workman, Ashley Jacobs, Alexander J. Vogel, Shirley A. Condon, Deborah M. Brown · 2014 · PLoS ONE
  61. Avian Influenza Viruses, Inflammation, and CD8+ T Cell Immunity
    Zhongfang Wang, Liyen Loh, Łukasz Kedzierski, Katherine Kedzierska · 2016 · Frontiers in Immunology
  62. The life cycle of a T cell after vaccination – where does immune ageing strike?
    Chulwoo Kim, Fengqin Fang, Cornelia M. Weyand, Jörg J. Goronzy · 2016 · Clinical & Experimental Immunology
  63. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
    Kristin Greve-Isdahl Mohn, Fan Zhou, Karl Albert Brokstad, Saranya Sridhar, Rebecca Jane Cox · 2017 · The Journal of Infectious Diseases
  64. Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head
    Lidewij Wiersma, Guus F. Rimmelzwaan, Rory D. de Vries · 2015 · Vaccines
  65. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8 + T cell responses
    Germain J. P. Fernando, Jin Zhang, Hwee-Ing Ng, Oscar L. Haigh, Sally R. Yukiko, Mark A.F. Kendall · 2016 · Journal of Controlled Release
  66. Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine
    Luis Martínez‐Sobrido, Olve B. Peersen, Aitor Nogales · 2018 · Viruses
  67. The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease
    Katherine Kedzierska, Marios Koutsakos · 2020 · Viral Immunology
  68. High Frequency of Cytolytic 21-Hydroxylase–Specific CD8+ T Cells in Autoimmune Addison’s Disease Patients
    Amina Dawoodji, Ji‐Li Chen, Dawn Shepherd, Frida Dalin, Andrea Tarlton, Mohammad Alimohammadi, Marissa Penna-Martinez, Gesine Meyer, Anna Louise Mitchell, Earn H Gan et al. · 2014 · The Journal of Immunology
  69. Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus
    Andrea J. Sant, Katherine A. Richards, Jennifer Lynn Nayak · 2018 · Current Opinion in Immunology
  70. Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity
    Sara Herrera de la Mata, Ciro Ramírez-Suástegui, Heena M Mistry, Francisco Emmanuel Castañeda-Castro, Aref Kyyaly, Hayley A. Simon, Shu Ying Liang, Laurie C.K. Lau, Clair Barber, Monalisa Mondal et al. · 2023 · Med
  71. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection
    Korey Demers, George Makedonas, Marcus Buggert, Michael A. Eller, Sarah J. Ratcliffe, Nilu P Goonetilleke, Chris K. Li, Leigh Anne Eller, Kathleen Rono, Lucas Maganga et al. · 2016 · PLoS Pathogens
  72. Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
    Eva van Doorn, Heng Liu, Tamar Ben-Yedidia, Shimon Hassin, Ildikó Visontai, Stephen Norley, Henderik Willem Frijlink, Eelko Hak · 2017 · Medicine
  73. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes
    Liudmila A. Stepanova, Eugenia S. Mardanova, Marina A. Shuklina, Elena A. Blokhina, Roman Y. Kotlyarov, Marina V. Potapchuk, Anna A. Kovaleva, Inna G. Vidyaeva, Alexandr V. Korotkov, Elizaveta I. Eletskaya et al. · 2018 · Journal of Biomedical Science
  74. Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine
    Christopher E. Lopez, Kevin L. Legge · 2020 · Vaccines
  75. CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination
    Junbao Yang, Eddie A. James, Theresa J. Gates, Jonathan Howard DeLong, Rebecca E. LaFond, Uma Malhotra, William W. Kwok · 2013 · International Immunology
  76. Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons
    Jesús Castilla, Ana Navascués, Mirian Fernández-Alonso, Gabriel Reina, Francisco Pozo, Itziar Casado, Marcela Guevara, Iván Martínez‐Baz, Aurelio Barricarte, Carmen Ezpeleta · 2016 · Vaccine
  77. Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
    Alexander I. Makarkov, Makan Golizeh, Elizabeth Ruiz-Lancheros, Angelica A. Gopal, Ian N. Costas-Cancelas, Sabrina Chierzi, Stéphane Pillet, Nathalie Charland, Nathalie Landry, Isabelle Rouiller et al. · 2019 · npj Vaccines
  78. Impaired HA-specific T follicular helper cell and antibody responses to influenza vaccination are linked to inflammation in humans
    Danika Lea Hill, Carly E. Whyte, Silvia Innocentin, Jia Le Lee, James Dooley, Jiong Wang, Eddie A James, James Christopher Lee, William W Kwok, Martin Stuart Zand et al. · 2021 · eLife
  79. Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial
    Thomas G Evans, Louise Bussey, Elizabeth Eagling-Vose, Kathryn Rutkowski, Chris Ellis, Chris Argent, Paul Matthew Griffin, Joshua Kim, Susan Thackwray, Sepehr Shakib et al. · 2022 · The Lancet Infectious Diseases
  80. Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Chang Kyung Kang, Hang‐Rae Kim, Kyoung‐Ho Song, Bhumsuk Keam, Seong Jin Choi, Pyoeng Gyun Choe, Eu Suk Kim, Nam Joong Kim, Yu Jung Kim, Wan Beom Park et al. · 2020 · The Journal of Infectious Diseases
  81. Asymptomatic HIV-infected Individuals on Antiretroviral Therapy Exhibit Impaired Lung CD4+ T-Cell Responses to Mycobacteria
    Kondwani Jambo, Dominic H. Banda, Louise Afran, Anstead Kankwatira, Rose D. Malamba, Theresa J. Allain, Stephen B. Gordon, Robert S. Heyderman, David G. Russell, Henry Charles Mwandumba · 2014 · American Journal of Respiratory and Critical Care Medicine
  82. Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
    Seyed Davoud Jazayeri, Chit Laa Poh · 2019 · Vaccines
  83. Landscape of coordinated immune responses to H1N1 challenge in humans
    Zainab Rahil, Rebecca A. Leylek, Christian M. Schürch, Han M. Chen, Zach B. Bjornson, Shannon R. Christensen, Pier Federico Gherardini, Salil S. Bhate, Matthew H. Spitzer, Gabriela K. Fragiadakis et al. · 2020 · Journal of Clinical Investigation
  84. Controlled Human Infection Models To Accelerate Vaccine Development
    Robert K. M. Choy, August Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca Sheets, Jorge Flores · 2022 · Clinical Microbiology Reviews
  85. Human T cells efficiently control RSV infection
    Chandrav De, Raymond John Pickles, Wenbo Yao, Baolin Liao, Allison C. Boone, Mingyu Choi, Diana M. Battaglia, Frederic Barton Askin, Jason K. Whitmire, Guido Silvestri et al. · 2023 · JCI Insight
  86. Conserved epitopes dominate cross‐ CD 8+ T ‐cell responses against influenza A H 1 N 1 virus among A sian populations
    Jun Liu, Bin Wu, Shihong Zhang, Shuguang Tan, Yeping Sun, Zhujun Chen, Yuanfang Qin, Mingwei Sun, Guoli Shi, Ying Wu et al. · 2013 · European Journal of Immunology
  87. Influenza vaccines: T-cell responses deserve more attention
    Michael Schotsaert, Xavier Saelens, Geert G Leroux-Roels · 2012 · Expert Review of Vaccines
  88. Consumption of Bifidobacterium animalis subsp. lactis BB‐12 impacts upper respiratory tract infection and the function of NK and T cells in healthy adults
    Huicui Meng, Yujin Lee, Zhaoyong Ba, Jiayu Peng, Junli Lin, Alexander S. Boyer, Jennifer A Fleming, Emily J. Furumoto, Robert Roberts, Penny M. Kris‐Etherton et al. · 2016 · Molecular Nutrition & Food Research
  89. Influenza (Including Avian Influenza and Swine Influenza)
    John J. Treanor · 2015 · Elsevier eBooks
  90. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
    Sophie Steiner, Franziska Sotzny, Sandra Bauer, Il‐Kang Na, Michael Schmueck‐Henneresse, Victor M. Corman, Tatjana Schwarz, Christian Drosten, Désirée J. Wendering, Uta Behrends et al. · 2020 · Frontiers in Immunology
  91. Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
    Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S. Heitmann, Marissa Lisa Dubbelaar, Andreas Peter, Sebastian Hörber, Jens Bauer, Jonas Rieth et al. · 2021 · Cancer Discovery
  92. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
    Joseph Yunis, Kirsty Renfree Short, Di Yu · 2023 · Trends in Microbiology
  93. Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+M 1 coadministration with inactivated influenza vaccine
    Caitlin E. Mullarkey, Amy C. Boyd, Arjan van Laarhoven, Eric A. Lefèvre, Brigid Veronica Carr, Massimiliano Baratelli, Eleonora Molesti, Nigel James Temperton, Colin Butter, Bryan Charleston et al. · 2013 · European Journal of Immunology
  94. Clearance of influenza virus infections by T cells: risk of collateral damage?
    Marine L. B. Hillaire, Guus F. Rimmelzwaan, Joost H. C. M. Kreijtz · 2013 · Current Opinion in Virology
  95. Human microbial challenge: the ultimate animal model
    Andrew John Pollard, Julian Savulescu, JOHN S. OXFORD, Adrian V. S. Hill, Myron M. Levine, David J. Lewis, Robert Charles Read, David Yates Graham, Wellington Sun, Peter Openshaw et al. · 2012 · The Lancet Infectious Diseases
  96. In VitroAssessment of the Immunological Significance of a Human Monoclonal Antibody Directed to the Influenza A Virus Nucleoprotein
    Rogier Bodewes, Martina M. Geelhoed-Mieras, Jens Wrammert, Rafi Ahmed, Patrick C. Wilson, Ron A. M. Fouchier, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan · 2013 · Clinical and Vaccine Immunology
  97. Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection
    Judith Helene Aberle, Julia Schwaiger, Stephan Walter Aberle, Karin Stiasny, Ondřej Scheinost, Michael Kundi, Václav Chmelı́k, Franz Xaver Heinz · 2015 · PLoS ONE
  98. Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studies
    Shobana Balasingam, Annelies Wilder‐Smith · 2016 · International Journal of Infectious Diseases
  99. The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination
    Allison L. Dauner, Pankaj B. Agrawal, Jose Salvatico, Tenekua M. Tapia, Vipra Dhir, S. Farzana Shaik, Donald R. Drake, Anthony M. Byers · 2017 · Vaccine
  100. Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo
    Anthony T. DiPiazza, Aitor Nogales, Nicholas C. Poulton, Patrick C. Wilson, Luis Martínez‐Sobrido, Andrea J. Sant · 2017 · Scientific Reports